Intra‐articular biomaterial injection as a management option for canine stifle disease: navigating the evidence gap

Intra-articular biomaterial injection as a management option for canine stifle disease: navigating the evidence gap MANAGING cranial cruciate disease (CCD) and its inevitable sequela, stifle osteoarthritis (OA), remains one of the most contentious areas in veterinary orthopaedics.For decades, the conversation has centred on a binary choice: surgical stabilisation or conservative management.However, a recent proof-of-concept study by Kleeman and colleagues, 1 summarised on p 426 of this issue of Vet Record, introduces a third, albeit controversial, option: intra-articular biomaterial injection as a palliative strategy for dogs where surgery is deferred.Kleeman and colleagues' study 1 signals a growing interest in non-cellular orthobiologic approaches for joint pain and prompts a necessary reflection on how veterinarians adopt emerging therapies.Canine CCD is not merely a mechanical failure.The dysregulation of synovial cell function and the rapid progression of OA, with osteophyte production occurring within seven days in experimental models, 2 mean that simply addressing joint instability does not fully resolve the underlying inflammatory cascade.Surgical procedures such as tibial plateau levelling osteotomy remain the gold standard for restoring function, particularly in medium-to-large breed dogs, by neutralising tibiofemoral shear forces.3 However, surgery carries substantial financial, logistical and emotional burdens for owners.Many owners are unable to pursue surgical treatment, either because it is unaffordable or because their dog is ineligible due to anaesthetic complications.Complications, including surgical site infections and implant failure, are also not negligible, and many owners either cannot afford or cannot accommodate the postoperative demands.Even if a dog is eligible for surgery and its owners can afford the procedure and meet postoperative demands, circumstances may require postponing it.This is particularly

Authors

Institutions

Publication Details

Journal
Veterinary Record
Published
2026-10-30
DOI
https://doi.org/10.1002/vetr.71338
Primary Topic
Veterinary Orthopedics and Neurology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intra‐articular biomaterial injection as a management option for canine stifle disease: navigating the evidence gap

Sebastián Cardona‐Ramírez
1 links
Veterinary Record
Veterinary Orthopedics and Neurology
article

Intra‐articular biomaterial injection as a management option for canine stifle disease: navigating the evidence gap

Sebastián Cardona‐Ramírez
article en

Abstract

Intra-articular biomaterial injection as a management option for canine stifle disease: navigating the evidence gap MANAGING cranial cruciate disease (CCD) and its inevitable sequela, stifle osteoarthritis (OA), remains one of the most contentious areas in veterinary orthopaedics.For decades, the conversation has centred on a binary choice: surgical stabilisation or conservative management.However, a recent proof-of-concept study by Kleeman and colleagues, 1 summarised on p 426 of this issue of Vet Record, introduces a third, albeit controversial, option: intra-articular biomaterial injection as a palliative strategy for dogs where surgery is deferred.Kleeman and colleagues' study 1 signals a growing interest in non-cellular orthobiologic approaches for joint pain and prompts a necessary reflection on how veterinarians adopt emerging therapies.Canine CCD is not merely a mechanical failure.The dysregulation of synovial cell function and the rapid progression of OA, with osteophyte production occurring within seven days in experimental models, 2 mean that simply addressing joint instability does not fully resolve the underlying inflammatory cascade.Surgical procedures such as tibial plateau levelling osteotomy remain the gold standard for restoring function, particularly in medium-to-large breed dogs, by neutralising tibiofemoral shear forces.3 However, surgery carries substantial financial, logistical and emotional burdens for owners.Many owners are unable to pursue surgical treatment, either because it is unaffordable or because their dog is ineligible due to anaesthetic complications.Complications, including surgical site infections and implant failure, are also not negligible, and many owners either cannot afford or cannot accommodate the postoperative demands.Even if a dog is eligible for surgery and its owners can afford the procedure and meet postoperative demands, circumstances may require postponing it.This is particularly

Veterinary RecordVol. 199(9)
Universidad de Antioquia (CO)
Good health and well-being
Openalex Percentile: Top 9%
Veterinary Orthopedics and Neurology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon